|
Volumn 118, Issue 3, 2014, Pages 690-
|
Why are we using pulse oximetry but not neuromuscular monitoring routinely: The real world scenario?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROMUSCULAR BLOCKING AGENT;
SUGAMMADEX;
ANESTHESIST;
HUMAN;
INTENSIVE CARE UNIT;
LETTER;
MORTALITY;
NEUROMUSCULAR MONITORING;
PRIORITY JOURNAL;
PULSE OXIMETRY;
TREATMENT OUTCOME;
ANDROSTANOLS;
CHOLINESTERASE INHIBITORS;
FEMALE;
GAMMA-CYCLODEXTRINS;
HUMANS;
MALE;
MUSCLE WEAKNESS;
NEOSTIGMINE;
NEUROMUSCULAR BLOCKADE;
NEUROMUSCULAR JUNCTION;
NEUROMUSCULAR MONITORING;
NEUROMUSCULAR NONDEPOLARIZING AGENTS;
|
EID: 84896893629
PISSN: 00032999
EISSN: 15267598
Source Type: Journal
DOI: 10.1213/ANE.0000000000000072 Document Type: Letter |
Times cited : (4)
|
References (4)
|